Sánchez P,
Meca-Lallana V,
Barbosa A,
Manzanares R,
Palmí I,
Vivancos J.
Tumefactive demyelinating lesions of 15 patients: Clinico-radiological features,
management and review of the literature.
J Neurol Sci.
2017 Oct 15;381:32-38.
Jain RS,
Khan I,
Kandelwal K,
Desai T.
Tumefactive demyelinating lesions (TDLs): A case series of clinicoradiological features.
Clin Neurol Neurosurg.
2017 Nov;162:91-94.
Katdare A,
Ursekar M.
Systematic imaging review: Multiple Sclerosis.
Ann Indian Acad Neurol.
2015 Sep;18(Suppl 1):S24-9.
Algahtani H,
Shirah B,
Alassiri A.
Tumefactive demyelinating lesions: A comprehensive review.
Mult Scler Relat Disord.
2017 May;14:72-79.
Ashrafi MR,
Tavasoli AR,
Alizadeh H,
Zare Noghabi J,
Parvaneh N.
Tumefactive Multiple Sclerosis Variants: Report of Two Cases of Schilder and Balo Diseases.
Iran J Child Neurol.
2017 Spring;11(2):69-77.
Bastianello S,
Pichiecchio A,
Spadaro M,
Bergamaschi R,
Bramanti P,
Colonnese C,
Sabatini U,
Uggetti C,
Luccichenti G.
Atypical multiple sclerosis: MRI findings and differential diagnosis.
Neurol Sci.
2004 Nov;25 Suppl 4:S356-60.
Lapointe E,
Li DKB,
Traboulsee AL,
Rauscher A.
What Have We Learned from MR Imaging in Multiple Sclerosis? AJNR Am J Neuroradiol.
2018 Jan 4.
Jiménez Arango JA,
Uribe Uribe CS,
Toro González G.
Lesser-known myelin-related disorders: focal tumour-like demyelinating lesions.
Neurologia.
2015 Mar;30(2):97-105.